News
#US Researchers Are Conducting a Clinical Trial Designed to Help Understand Rare but ... - Latest Tweet by IANS India
The latest Tweet by IANS India states, '#US researchers are conducting a clinical trial designed to help understand rare but potentially serious systemic allergic reactions to #COVID19 mRNA vaccines, the National Institutes of Health announced.'
#US researchers are conducting a clinical trial designed to help understand rare but potentially serious systemic allergic reactions to #COVID19 mRNA vaccines, the National Institutes of Health (@NIH) announced. pic.twitter.com/duoOFVOKlO— IANS Tweets (@ians_india) March 10, 2022
(The above story first appeared on LatestLY on Mar 10, 2022 02:22 PM IST. For more news and updates on politics, world, sports, entertainment and lifestyle, log on to our website latestly.com).
